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Abstract
Introduction The use of vascular plug devices for the
occlusion of high-flow lesions is a relatively new and
successful procedure in peripheral and cardiopulmonary
interventions. We report on the use and efficiency of the
Amplatzer vascular plug in a small clinical series and
discuss its potential for occlusion of large vessels and high-
flow lesions in neurointerventions.
Methods Between 2005 and 2007 four patients (mean age
38.5 years, range 16–62 years) were treated with the device,
in three patients to achieve parent artery occlusion of the
internal carotid artery, in one patient to occlude a high-flow
arteriovenous fistula of the neck. The application, time to
occlusion, and angiographic and clinical results and the
follow-up were evaluated.
Results Navigation, positioning and detachment of the
device were satisfactory in all cases. No flow-related
migration of the plug was seen. The cessation of flow was
delayed by a mean of 10.5 min after deployment of the first
device. In the procedures involving vessel sacrifice, two
devices had to be deployed to achieve total occlusion. No
patient experienced new neurological deficits; the 3-month
follow-up revealed stable results.
Conclusion The Amplatzer vascular plug can be adapted
for the treatment of high-flow lesions and parent artery
occlusions in the head and neck. In this small series the use
of the devices was uncomplicated and safe. The rigid and
large delivery device and the delayed cessation of flow
currently limit the device’s use in neurointerventions.
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Introduction
The clinical efficiency of the Amplatzer vascular plug
(AVP; AGA Medical, Golden Valley, MN) has been
described for the occlusion of various pulmonary, coronary
and peripheral vessels including in patients with fistulas
and arteriovenous malformations in different locations [1–
5]. The transfer of the technology to the field of neuro-
interventions might therefore be feasible as occlusion of
high-flow vascular lesions and sacrifice of large cervical
vessels are common neurointerventional procedures. At
present, embolic devices such as coils and balloons are
predominantly used for these purposes [6–9]. Theoretically,
the AVP combines the advantages of a coil with the
possibility of resheathing and detaching the device precise-
ly and has the advantage of the straightforward single-step
vessel occlusion of a balloon. This embolization approach
is relatively new to the neurointerventional field and to date
the role of vascular occlusion plugs in these procedures has
rarely been documented in the literature [10, 11]. Specific
neuroradiological aspects such as the thromboembolic
potential have not been evaluated yet.
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Consequently, to address the need for more data, we
evaluated our experience using the AVP in a few different
interventions and report the application, safety and effi-
ciency of the device and its potential for occlusion of high-
flow vessels and lesions.
Methods
Device design and application
The Amplatzer vascular plug was initially designed for
interventions in the peripheral vasculature. The cylindrical
device consists of a self-expanding nitinol wire mesh
(Fig. 1) and comes in different diameters from 4 mm to
16 mm (in 2-mm increments). Selection of a device
diameter 30–50% larger than the vessel is recommended.
Each end is radioopacified by a platinum-iridium marker.
The device is mounted on a stainless steel delivery wire.
The detachment system consists of a microscrew, untight-
ened by clockwise rotation of the wire. Until detachment, it
is possible to resheath and redeploy the device to improve
positioning. It is possible to control the stability of the
position by gentle movement of the delivery wire before
definitive detachment. Due to the radial force of the device
and the oversized diameter it anchors to the vessel wall.
The high friction with the intima does not allow navigating
the unsheathed device within the vessel. The device is
deployed directly from the guide catheter. Depending on
the diameter of the selected device a 5F to 8F application/
guide catheter is required. At present its use in neuro-
interventions is “off-label”.
Evaluation and intervention
Since January 2005 four patients (mean age 38.5 years,
range 16–62 years) have been treated in our department
with the device. In three patients a parent artery occlusion
(PAO) of the internal carotid artery (ICA) was performed
using the AVP. These patients had a giant aneurysm of the
cavernous ICA, a false aneurysm of the cavernous ICAwith
massive trans-sphenoidal haemorrhage after ENT surgery, a
direct carotid-cavernous fistula (CCF) type after head
trauma, and a growing, haemodynamically relevant arterio-
venous fistula (AVF) of the neck. Angiography and the
interventions were performed under general anaesthesia.
Intraarterial digital subtraction angiography (DSA) was
carried out on a biplane high-resolution angiography
system (Toshiba CAS500, Tokyo, Japan). Patient data and
details of the interventions carried out are shown in Table 1.
Before PAO detailed DSA to analyse the flow pattern
and/or ipsilateral test balloon occlusion to evaluate the
intracranial cross-flow were performed. Preinterventional
angiography included injection of the common carotid
artery (CCA), ICA and external carotid artery (ECA). The
extent and supply of the aneurysm, AVF and CCF were
documented in multiple projections. To reduce the risk of
thromboembolic complications a continuous flush with
heparinized sodium chloride solution (5 IU/ml) was
administered. No postprocedural anticoagulation (e.g. aspi-
rin) was administered. In three patients bare platinum coils
(Boston Scientific Target, Fremont, CA) were additionally
placed. In one patient fibred coils were additionally used to
occlude a CCF. Control angiography revealed the flow
conditions of the embolized vessel segment and time to
occlusion (between the deployment of the first AVP and
disruption of flow) was documented. All patients under-
went a 3-month follow-up to document the long-term
result.
Results
In all patients the deployment of the AVP led to total
occlusion of the vessel/AVF. The AVP were deployed using
6-8F guide catheters. In the three patients with PAO of the
ICA, two devices were required to achieve flow arrest. The
mean time to total occlusion of the vessel segment after
deployment of the first AVP was 10.5 min (range 9–
12 min). Navigation of the device was limited due to the
Fig. 1 The cylindrical AVP and
the positioning and detachment
wire (a) and the front view of
the dense nitinol mesh (b)
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rigid and large guide catheter. However, in this limited
study in each patient the device was deployed in the target
position. The process of detachment was uncomplicated
and safe. Once the AVP was detached, no device migration
was observed. None of the patients developed new
neurological deficits in the postinterventional course. The
follow-up revealed stable vessel occlusion in all patients.
Illustrative cases
Patient 1
An 18-year-old man presented to our emergency depart-
ment after severe head trauma from a road accident. A
cranial CT scan revealed traumatic intracerebral and
subarachnoid haemorrhage. Multiple fractures of the scull
base involved both pyramids and the sphenoid bone and
crossed the carotid canal. Bone fragments were found in the
left carotid canal and cavernous sinus. DSA performed
3 days later showed a CCF type A on the left side with the
typical draining pattern and dilated cortical veins (Fig. 2).
Right carotid and vertebral angiography revealed spontane-
ous cross-flow to the distal left ICA.
After placement of a 7F catheter sheath in the right
femoral artery a 7F guiding catheter was placed in the
cervical segment of the left ICA. Subsequently a micro-
catheter (FastTracker 18; Boston Scientific Target, Fremont,
CA) was advanced and passed into the left cavernous sinus.
Due to the extension of the CCF from the distal petrous to
the intracavernous segment of the ICA, occlusion of the
fistula or preservation of the ICA was not indicated. The
target of the intervention was stable occlusion of the ICA
proximally and distally to the extended lesion of the vessel
wall. Guglielmi detachable coils (GDC) and fibred coils
were deployed via the microcatheter in the cavernous
segment of the ICA. The control angiogram excluded any
residual distal inflow to the fistula from the contralateral
side. However, the ipsilateral flow to the fistula was
significantly reduced but not disrupted after coil placement.
In this specific setting of a partially treated CCF type A an
AVP (8 mm×7 mm) was navigated and detached in the
upper cervical segment of the ICA. Navigation further
distally into the petrous segment was abandoned due to the
high friction between the device and the vessel wall. After
detachment the device led immediately to a further
reduction in flow but total cessation was not attained.
Combination with a second AVP of the same size placed
proximally than achieved total occlusion of the left ICA and
therefore the occlusion of the CCF. The 3-month follow-up
revealed stable occlusion of the CCF and left ICA.
Patient 2
A 16-year-old boy presented with a high-flow AVF located
at the left side of the neck. The lesion was haemodynami-
cally relevant and had caused a left ventricular enlargement.
DSA revealed a markedly enlarged feeder originating from
the left ECA (Fig. 3). The fistula (4.5 mm in diameter)
drained directly into the left external jugular vein. No
stenosis of the cervical veins was demonstrated. The
intracranial venous drainage was not compromised; a
cranial MRI scan showed no brain oedema.
After placement of two catheter sheaths in the right
femoral artery and femoral vein, both the single feeding
ECA branch and the draining vein were catheterized with
6F guiding catheters. The venous guide catheter was
navigated through the fistula point guided by a biplane
road map obtained form arterial injection of contrast agent.
During slow retraction of the catheter into the external
jugular vein the 8 mm×7 mm AVP was placed in the fistula
and subsequently detached. Immediate angiography per-
formed from the arterial catheter showed a marked
reduction in flow in the fistula. Ten minutes after
detachment of the device the flow in the fistula was
disrupted. Consequently, no additional coil treatment had
to be performed and the procedure was terminated. Clinical
and ultrasound examination after the intervention and after
6 months revealed stable occlusion of the fistula.
The two other patients presented with a giant aneurysm
and pseudoaneurysm of the ICA. In both patients the parent
artery was occluded after the deployment of two AVP
devices through an 8F guiding catheter. The distal device
was placed into the distal cervical ICA, and navigation into
the petrous ICA was not attempted. In both patients
placement of a second and proximal device led to total
cessation of flow.
Table 1 Patient data
Age (years) Gender Vascular lesion Vessel occluded Guide catheter (F) No. of AVP
deployed
Additional coils Time to total
occlusion (min)
18 M CCF type A ICA 7 2 GDC/fibred 12
16 M AVF of the neck Fistula point 6 1 – 10
58 F ICA giant aneurysm ICA 8 2 GDC 11
62 M ICA pseudoaneurysm ICA 8 2 GDC 9
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Discussion
Using a vascular plug device for occlusion of high-flow
vascular lesions is an established procedure in peripheral and
cardiopulmonary interventions [1–5]. Occlusion of high-flow
vascular lesions and sacrifice of large cervical vessels are
common neurointerventional procedures, and the recent
transfer of the technology to the field of neurointerventions
may therefore be a promising development.
At present, endovascular occlusion of these lesions
primarily relies on the use of coils and balloons. Coils
have the advantage of a very precise placement and
detachment. The drawback is the occasionally unstable
anchorage at the vessel wall due to the small interface.
Fig. 2 DSA in an 18-year-old
man with a left-sided CCF type
A. a, b AP (a) and lateral (b)
projections show that the left
ICA terminates in the fistula and
does not contribute to the intra-
cranial perfusion. c The cavern-
ous sinus drains into the inferior
petrosal and pterygoid sinus,
and the cortical veins are dilat-
ed. d After coil placement the
distal inflow zone to the fistula
is occluded and the ipsilateral
ICA still feeds the fistula. e Two
AVP devices are precisely
placed and detached within the
cervical segment of the ICA.
Immediately after placement the
flow is reduced at the level of
the proximal device (white
arrows). f The ICA is subse-
quently totally occluded at the
level of the distal AVP (black
arrows)
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Therefore, the coil ball might be prone to distal migration
(e.g. pushable coils or the initially deployed detachable
coil). Additionally, the use of multiple coils to occlude an
artery is a step-wise, therefore time-consuming, procedure.
This time between deployment of the device and total
occlusion of the vessel provides an opportunity for the
generation thromboembolic complications, and should
therefore be minimized in brain-supplying vessels. Some
centres use fibred coils [12] or Hydrogel-coated coils
(MicroVention, Aliso Viejo, CA) to improve the volumetric
filling, reduce the number of coils and accelerate the
occlusion process [13, 14]. Occlusion using coils is,
furthermore, a relatively expensive procedure.
A detachable balloon, on the other hand, allows a single-
step occlusion of a vessel or vascular lesion. The risk of
thromboembolic events from a clotting process is therefore
minimized. Conversely, the deployment of the balloon is
challenging and carries the risk of unintentional detachment
or early deflation with embolization of the device itself. To
prevent early deflation of the balloon, in some centres a
hardening embolic material (e.g. a polymer) is used for the
final inflation before detachment. This method, however,
hinders any further repositioning attempts. The balloon
does not anchor itself to the vascular wall and is therefore
prone to flow-induced migration. Therefore the placement
of second balloon proximally might be necessary.
The AVP combines some of the advantages of coils and
balloons. The navigation of the catheter and the device was
uncomplicated in the selected patients including the
presented venous approach. The possibility to resheath
and reposition the device in combination with a safe and
uncomplicated detachment system allowed precise posi-
tioning in clinical use. In addition, because of its cylindrical
design and high radial force, the device fixes to the vessel
wall. No migration of the device was observed clinically.
The results in the reported patients were stable during the
follow-up period. Furthermore, the device is inexpensive
(500 US$ per device regardless of size) compared to the use
of multiple coils.
During our limited clinical experience two aspects
emerged as possible limitations. First, the rather rigid
delivery wire with the microscrew for detachment limits
the navigability of the device in tortuous vessels. In
combination with the large guide catheter (minimum 5F)
the device is not suitable for use in small-calibre vessels or
the intracranial vasculature. Second, the nitinol wire mesh
of the AVP significantly reduces flow in the vessel or
vascular lesion, even in high-flow lesions as discussed in
Fig. 3 DSA in a 16-year-old boy with a high-flow AVF. a Left-sided
CCA injection reveals the high-flow AVF supplied by the main trunk
of the ECA and draining via the internal jugular vein. The AP
projection illustrates reduced flow in the ICA territory. b Injection of
contrast agent via the arterial guide catheter in the ECA demonstrates
the arteriovenous fistula point (arrowhead). c A second catheter is
placed in the proximal internal jugular vein (pair of asterisks) in
proximity to the fistula point (single asterisk first catheter). d The AVP
device is placed across the fistula point (black arrows) and detached. e
The control angiogram reveals total occlusion of the fistula at the
arterial border of the device (white arrows). f The final angiogram
demonstrates total occlusion of the fistula and improvement of the
flow in the ICA territory
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this report. But compared to balloon occlusion, during PAO
complete cessation of flow is delayed (mean 10.5 min).
This delay represents a possible window for thromboem-
bolic complications during PAO during neurointerventions.
Consequently, in interventions requiring ICA sacrifice two
devices had to be deployed to achieve occlusion in a
reasonable time frame [10, 11]. Both of these limitations
indicate the need for adaptation of the device to meet the
demands of neurointerventional procedures. A more deli-
cate delivery system would enable the placement in various
locations during neuroradiological procedures. The current
design seems to hinder intracranial use. Furthermore, a
higher efficiency in reducing flow (e.g. denser nitinol mesh
or coating) might allow a single-step occlusion and reduce
the risk of arterioarterial thromboembolism.
Conclusion
The AVP can be used for the treatment of high-flow lesions
and parent artery occlusions in the head and neck. In this
small series the use of the devices was uncomplicated and
safe. Its method of placement and the delayed cessation of
flow limits its use for neurointerventions.
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